Frederick Tay
Frederick is with the firm’s corporate practice, specialising in mergers and acquisitions and corporate transactions. He has more than 10 years of experience in the healthcare and consumer healthcare industry.
In the healthcare and life sciences industry, Frederick has advised and implemented both operational and transactional solutions for companies which include advising on supply contracts for active pharmaceutical ingredients in the manufacturing process, pricing and supply of medicines contracts with both public and private healthcare practices, advising on cross-border transactions globally, and advising on digital projects.
Contact Information:
All Posts:
Commentary
What Singapore’s app store rules reveal about the future of online trust
Faster hiring alone will not fix construction’s productivity problem
Beyond policy: How Singapore's service sector can win at the frontline
Solving the production problem behind Singapore’s ‘pilot purgatory’
Transformation without disruption: Your Existing ERP is an accelerant to business innovation
From Singapore to Southeast Asia: Thriving in innovation by knowing when to pause
Section 13O, MAS, and the digital footprint of Singapore Family Offices
Could Singapore lead the world's next management revolution?
RIE2030’s real test: Turning innovation into impact
What Singapore logistics operators often overlook when electrifying fleets